Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common shares, US$0.001 nominal value per share
-
Shares outstanding
-
1.85B
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
8.75M
-
Shares change
-
+3.36M
-
Total reported value, excl. options
-
$155M
-
Value change
-
+$59.4M
-
Number of buys
-
30
-
Price
-
$17.72
Significant Holders of VEON Ltd. - Common shares, US$0.001 nominal value per share (VEON) as of Q1 2023
33 filings reported holding VEON - VEON Ltd. - Common shares, US$0.001 nominal value per share as of Q1 2023.
VEON Ltd. - Common shares, US$0.001 nominal value per share (VEON) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.75M shares
of 1.85B outstanding shares and own 0.47% of the company stock.
Largest 10 shareholders include Exor Capital LLP (5.39M shares), Helikon Investments Ltd (707K shares), Solus Alternative Asset Management LP (510K shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (501K shares), WELLINGTON MANAGEMENT GROUP LLP (496K shares), DG Capital Management, LLC (287K shares), Kopernik Global Investors, LLC (243K shares), GABELLI FUNDS LLC (155K shares), Russell Investments Group, Ltd. (118K shares), and UBS ASSET MANAGEMENT AMERICAS INC (68K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.